The 20th Japan- taiwan- korea Joint Conference for Gynecological Pathology Theme: Vulvar and Vaginal tumor Time Table



Download 254.99 Kb.
Page1/9
Date conversion31.01.2017
Size254.99 Kb.
  1   2   3   4   5   6   7   8   9

The 20th Japan- Taiwan- Korea

Joint Conference for Gynecological Pathology

Theme: Vulvar and Vaginal tumor


Time Table

Time

9:30 – 10:20

Program

Registration

10:20 10:40


Opening Address




Toshiharu Matsumoto, M.D.

Representative of the Japanese Study Group




Chiung-Ru Lai, M.D.

Representative of the Taiwan Study Group




Dong Won Kim, M.D.

Representative of the Korean Study Group










10:40 – 10:50

10:50 – 11:40


Congratulation address on the 20th Anniversary

Atsuhiko Sakamoto, M.D., Omori Red Cross Hospital


Special Lecture:

The Development of an External Quality Assurance Program for HPV Genotyping in Korea

Speaker: Sung Ran Hong, M.D., Cheil General Hospital, Dankook

University



Moderator: In Sun Kim, M.D., Jinju Korea Hospital


11:40 – 12:40

Mini Lecture I:

Pathology of vulvovaginal mesenchymal tumors

Speaker: Masaharu Fukunaga, M.D., Shin-yurigaoka General Hospital

Moderator: Chiung-Ru Lai, Taipei Veterans General Hospital
Mini Lecture II:

Vulvovaginal Stromal Tumor and Tumor-Like Lesion

Speaker: Chen Pi Yu, Changhua Christian Hospital

Moderator: In Ae Park M.D., Seoul National University Hospital
Mini Lecture III:

Vulvar Squamous carcinoma and precancerous lesion

Speaker: Kyu Rae Kim, M.D., Asan Medical Center, Ulsan University

Moderator: Miki Kushima, M.D., Showa University, Koutou-Toyosu Hospital

12:40 – 14:00

Lunch (Business Meeting)


14:00 – 15:00

Slide Conference: Session I

Moderator: Toshiharu Matsumoto, M.D., Juntendo University Nerima Hospital

Kwang Sun Suh, M.D., Chungnam National University Hospital



J-1

Wei-Xia Peng, M.D., Nippon Medical School

T-1


Hsiang-Lin Song, M.D., National Taiwan University Hospital, Hsinchu branch

K-1

Yi Kyeong Chun,M.D., Cheil General Hospital, Dankook University


15:00 – 16:30

Poster Session (Coffee Break)

Moderator: Shih-Ming Jung, M.D., Chang Gung Memorial Hospital

Masanori Yasuda, M.D., Saitama Medical University

International Medical Center

Chong Woo Yoo, M.D., National Cancer Center



16:30 – 17:30

Slide Conference: Session II

Moderator: Ming Chieh Lin, M.D.

Jong Hee Nam, M.D., Chonnam National University Hospital



J-2

Asumi Sakaguchi, M.D., Juntendo University Nerima Hospital

T-2

Koping Chang, M.D., National Taiwan University Hospital

K-2

Cheol Lee, M.D., Seoul National University Hospital

17:30-18:00

Closing Remark and Photo

18:00-20:00

Dinner

Special Lecture

Moderator: In Sun Kim, M.D., Ph.D., Jinju Korea Hospital

The Development of an External Quality Assurance Program

for HPV Genotyping in Korea

Sung Ran Hong, M.D., Ph.D.

Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine.

Background

Cervical cancer is still a leading lethal cancer and the third most common cancer among women worldwide, and the 6th most common in Korean women. Human papillomavirus (HPV) infection is a major cause of cervical cancers (>99%). The most important high risk HPV16 and HPV18 account for about 70% of all invasive cervical cancers worldwide.

In our country, different HPV DNA detection and genotyping kits have been established for diagnosing and monitoring HPV-related disease in clinical practice and for research, since 2004. Most of them target the highly conserved region of the HPV L1 gene. The genotyping assays usually differ in their analytical performances with regard to type-specific sensitivities and specificities. However, there was a lack of reference materials to standardize the methods for HPV genotyping.

The Korean CDC constructed candidate reference materials comprising 16 targets (HPV6, -11, -16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, -66, and 68). They were composed of recombinant HPV DNA plasmids including the full-length L1 protein. We evaluated whether the candidate reference materials could be used as the reference for HPV detection and genotyping using quantitative real-time polymerase chain reaction. Our results suggest that these reference materials may provide useful standards for standardizing quality assurance for different HPV-typing assays and for proficiency testing in diagnostic laboratories.

We have twice done two similar studies. The first 2014-subject was the development of an external quality assurance (EQA) program for HPV genotyping, and the second 2015-subject was the practical usage of EQA program for HPV genotyping.

  1   2   3   4   5   6   7   8   9


The database is protected by copyright ©dentisty.org 2016
send message

    Main page